BioHealth News Archive

MaxCyte Debuts New State-of-the-Art Headquarters in Maryland’s I-270 Biotech Corridor

MaxCyte Debuts New State-of-the-Art Headquarters in Maryland’s I-270 Biotech Corridor

ROCKVILLE, Md., Sept. 21, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies…

Read More

White House Unveils Strategy To Grow Trillion Dollar U.S. Bioeconomy

The U.S. bioeconomy is booming. Valued at nearly one trillion dollars and predicted to grow globally to over $30 trillion over the next two…

Read More
UCSF scientist says Biden’s cancer moonshot achievable

UCSF scientist says Biden’s cancer moonshot achievable

OAKLAND, Calif. - President Biden revived his call for a nationwide cancer moonshot effort on Monday, as he marked the 60th anniversary of President…

Read More
The Venture Capital Landscape Is Changing, and Perhaps Not for the Better | Maryland Smith

The Venture Capital Landscape Is Changing, and Perhaps Not for the Better | Maryland Smith

Startup companies have traditionally looked for the most experienced venture capitalists they could find to get their businesses off the ground and support their…

Read More

The University of Maryland Medical System is investing $14M in statewide economic development – Technical.ly

One of Maryland’s premiere medical networks just announced an eight-figure investment into the economic development of local and marginalized communities by way of notable…

Read More
Virginia’s AMPEL BioSolutions New Breakthrough Test Detects and Predicts Severity of COVID-19

Virginia’s AMPEL BioSolutions New Breakthrough Test Detects and Predicts Severity of COVID-19

CHARLOTTESVILLE, Va., Sept. 15, 2022 /PRNewswire/ -- AMPEL BioSolutions today announced a breakthrough in precision and personalized medicine that can detect and predict the severity of COVID-19 in…

Read More
Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases

Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases

Waltham, Mass. and Dublin – August 15, 2022 — Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and Horizon Therapeutics plc (Nasdaq: HZNP), today announced…

Read More
Streck Announces Series B Investment in Virginia’s Ceres Nanosciences

Streck Announces Series B Investment in Virginia’s Ceres Nanosciences

La Vista, Nebraska — September 14, 2022 – Streck announced today a Series B investment in Ceres Nanosciences (Ceres). The funds from this investment…

Read More
Swimming With Sharks

Swimming With Sharks

Swimming with Sharks pairs aspiring healthcare entrepreneurs with successful innovators and investors. The startups selected will pitch at the American Society of Anesthesiologists (ASA)…

Read More
Maryland Stem Cell Research Commission Announces Over $4 Million in Awards to Accelerate Cures | MSCRF

Maryland Stem Cell Research Commission Announces Over $4 Million in Awards to Accelerate Cures | MSCRF

September 13, 2022—The Maryland Stem Cell Research Commission announced it will grant $4,165,325 in award funding to innovative research that will strengthen and advance…

Read More
Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint

Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint

- The Company plans to work with the FDA to design a Phase 3 program in moderate-to-high systemic disease activity patients to begin in 2023, ahead…

Read More
Biden Spurs U.S. Biotechnology with New Order – Nextgov

Biden Spurs U.S. Biotechnology with New Order – Nextgov

The Biden administration announced the launch of a new national program dedicated to fortifying America’s biotechnology manufacturing industry in the latest executive effort to…

Read More
Qiagen joins monkeypox test-making efforts

Qiagen joins monkeypox test-making efforts

As the number of monkeypox cases around the world has ballooned since early May, so too has the list of diagnostic developers rapidly churning…

Read More
Alexandria Real Estate Equities, Inc. Recognizes Important Milestones in Its Pioneering of New York City’s Commercial Life Science Cluster, the Only Early-Stage Life Science Ecosystem Among the Major Life Science Clusters in the United States

Alexandria Real Estate Equities, Inc. Recognizes Important Milestones in Its Pioneering of New York City’s Commercial Life Science Cluster, the Only Early-Stage Life Science Ecosystem Among the Major Life Science Clusters in the United States

NEW YORK, Sept. 12, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ( NYSE: ARE), the first, longest-tenured and pioneering owner, operator and developer uniquely…

Read More
Finalists Selected For 7th Annual BioHealth Capital Region Crab Trap Competition

Finalists Selected For 7th Annual BioHealth Capital Region Crab Trap Competition

– Winner to be announced as part 2022 BioHealth Capital Region Forum – ROCKVILLE, MARYLAND, September 12, 2022 – A panel of investor judges…

Read More